Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy

NCT00603525 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
169
Enrollment
INDUSTRY
Sponsor class

Stopped Ofatumumab IV trials in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.

Conditions

Interventions

Sponsor

GlaxoSmithKline